Red Blood Cell Disease Diagnosis and Treatment Center
红细胞疾病诊疗中心 · Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin
Established in 1957 as the hospital's first department, this center operates two wards specializing in the diagnosis and treatment of various anemic disorders. It focuses on severe aplastic anemia (SAA), with outcomes described by the hospital as leading domestically and reaching international standards. The team manages complex conditions such as congenital dyserythropoietic anemia (CDA), Fanconi anemia, congenital dyskeratosis, hemochromatosis, and iron-refractory iron deficiency anemia. The center conducts national and provincial research on hematopoietic failure mechanisms, disease transformation in aplastic anemia, and new drug clinical trials. Staff have published over 100 articles, including more than 30 in SCI-indexed journals such as Blood and the British Journal of Haematology.
Conditions and treatments
- Diagnosis and treatment of severe aplastic anemia (SAA)
- Management of congenital dyserythropoietic anemia (CDA)
- Care for Fanconi anemia and congenital dyskeratosis
- Treatment of hemochromatosis
- Management of iron-refractory iron deficiency anemia
- Clinical trials for new drugs in hematologic disorders
Key facts
- Founded in 1957 as the first department of the hospital
- Operates two dedicated wards
- Published over 100 articles, including more than 30 in SCI-indexed journals
Rewritten in English from the department's own description on a public doctor-listing platform. Claims such as "leading" are the hospital's own.
| Doctors listed | 11 |
|---|---|
| Chief physicians | — |
We are an independent coordination service, not part of this hospital. Names and titles change; the hospital's website is the final word. How we build this directory.
Need a specialist's opinion?
Send your records and question. We find a specialist in the right field who reviews your case and tells you what they recommend.
Contact us